No quarterly revenue total was found in XSOLLA SPAC 1's SEC filings.
Xsolla Spac 1 (XSLL) files with the SEC under industry code 6770, Blank Checks.
Revenue
—
Net income
$1.66M
+50.1% vs prior quarter
Operating cash flow
$-153,190
-53.1% vs prior quarter
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- XSLL (Nasdaq), XSLLU (Nasdaq), XSLLW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Sherman Oaks, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2088807
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
|---|---|---|
| Operating income | -$145,106 | -$223,362 |
| Net income | $1.7M | $1.1M |
| Operating cash flow | -$153,190 | -$100,050 |
| Total assets | $209.0M | $207.2M |
| Total liabilities | $405,098 | $228,849 |
| Stockholders' equity | $1.4M | $1.6M |
| Cash and investments | $1.8M | $1.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 17, 2026 | Mar 17, 2026 |
| 10-Q | Quarterly report | Mar 16, 2026 | Sep 30, 2025 |
| 8-K |
Current report
Other events
|
Feb 6, 2026 | Feb 2, 2026 |
All 33 Xsolla Spac 1 SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.